'Significant Milestone' for Radionuclide Therapy in Refractory Meningioma

Published Date: 04 Oct 2024

Small study suggests large benefit for Lu-177 dotatate in intracranial disease

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

2.

Alkem introduces cetuximab under the trade name Cetuxa in India.

3.

Formaldehyde releasers found in common personal care products used especially by Black and Latina women

4.

FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC

5.

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot